中国实用医药2024,Vol.19Issue(4) :177-180.DOI:10.14163/j.cnki.11-5547/r.2024.04.047

阿昔替尼胃漂浮丸剂的制备及药效学研究

Preparation and pharmacodynamics of Axitinib gastric floating pellets

洪益平 裘方剑
中国实用医药2024,Vol.19Issue(4) :177-180.DOI:10.14163/j.cnki.11-5547/r.2024.04.047

阿昔替尼胃漂浮丸剂的制备及药效学研究

Preparation and pharmacodynamics of Axitinib gastric floating pellets

洪益平 1裘方剑1
扫码查看

作者信息

  • 1. 321000 金华市中医医院
  • 折叠

摘要

目的 制备阿昔替尼胃漂浮丸剂,延长其在胃肠道滞留时间,提高其口服生物利用度.方法 采用挤出滚圆法,分别以羟丙基甲基纤维素(HPMC)、羟丙基纤维素(HPC)为粘附阻滞材料,以碳酸氢钠(NaHCO3)为起泡剂,制备阿昔替尼胃漂浮丸剂.结果 以主药∶HPMC K100M∶HPC(2.5∶1∶5),主药∶起泡剂(1∶2)设计的处方,2 h释放达 37%,4 h释放达 67%,6 h释放达 80%.大鼠药代动力学研究结果表明,胃漂浮丸剂生物利用度提高 2.39 倍,Cmax提高 80%.结论 阿昔替尼生物粘附漂浮丸剂具有显著的缓释效果,可延长药物在体内的滞留时间,提高阿昔替尼在大鼠体内的口服生物利用度.

Abstract

Objective To prepare Axitinib gastric floating pellets,prolong its retention time in gastrointestinal tract and improve its oral bioavailability.Methods Axitinib gastric floating pellets were prepared by extrusion spheronization method with hydroxypropyl methylcellulose(HPMC)and hydroxypropyl cellulose(HPC)as adhesion blocking materials and sodium bicarbonate(NaHCO3)as foaming agent respectively.Results With the formulation of main drug∶HPMC K100M∶HPC(2.5∶1∶5)and main drug∶foaming agent(1∶2),the release rate was 37%at 2 h,67%at 4 h and 80%at 6 h.The pharmacokinetic study in rats showed that the bioavailability of gastric floating pellets was increased by 2.39 times,and Cmax was increased by 80%.Conclusion The bioadhesive floating pellets of Axitinib have significant sustained-release effect,can prolong the drug retention time in vivo,and improve the oral bioavailability of Axitinib in rats.

关键词

阿昔替尼/生物粘附漂浮/体外释放/药代动力学

Key words

Axitinib/Biological adhesion and floating/In vitro release/Pharmacokinetics

引用本文复制引用

基金项目

浙江省金华市科技计划项目(2019-4-055)

出版年

2024
中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
参考文献量12
段落导航相关论文